The anti-tumor efficiency of chimeric antigen receptor (CAR) T cells can also be improved by inducing the expression of the RNA Component Of Signal Recognition Particle 7SL1 (RN7SL1), secreted via EVs from CAR-T cells. This evidence concerns the gene RN7SL1 and neoplasm.